(BPH)
18,459 results
  • How does PSA change after water vapor therapy? A systematic review and meta-analysis. [Review]
    Prostate Cancer Prostatic Dis. 2026 Oct 06. [Online ahead of print]Scilipoti P, Chicaud M, … Kutchukian SPC
  • CONCLUSIONS: Rezūm therapy is associated with a reproducible PSA trajectory characterized by an early transient increase followed by a moderate decline from 3-12 months (~10%). Because this late change is non-significant and within the expected variability of PSA, it is unlikely to modify follow-up strategy. Awareness of this pattern may support appropriate interpretation of PSA measurements after MIST for BPH.
  • Human Prostate Cell Lines: Derivation, Molecular Characteristics and Appropriate Use. [Review]
    Prostate. 2026 Oct 06. [Online ahead of print]Abohamra H, Pearce KMP
  • CONCLUSIONS: Several descriptions repeated in the secondary literature are not supported by the primary characterization of the lines concerned. Selection of a line from the research question rather than from availability, verification of the relevant target in the working stock, authentication by short tandem repeat profiling, and full reporting of passage number and culture conditions would remove a substantial part of the variability presently seen in this literature.
  • Integrated Single-Cell and Bulk RNA Sequencing Reveals Inflammatory Microenvironment and Glycolysis-Driven Epithelial Proliferation in Benign Prostatic Hyperplasia. [Journal Article]
    J Inflamm Res. 2026; 19:636515.Ge J, Jiao W, … Zhang JJI
  • CONCLUSIONS: This study provides a comprehensive analysis of the inflammatory microenvironment and metabolic characteristics of BPH and identifies glycolysis-mediated proliferation of basal epithelial cells as a key driver of disease progression. Pharmacological inhibition of glycolysis with 2-deoxy-D-glucose reduced prostate weight, prostate index, epithelial proliferation and M1-like macrophage infiltration in vivo, indicating that targeting glycolytic metabolism is a promising therapeutic strategy for BPH. These findings offer novel insights into BPH pathogenesis and provide a rationale for developing metabolism-directed, and potentially locally delivered, interventions that could benefit patients who respond poorly to current medical therapy.